-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster III

Symposia: Cellular Immunotherapies: Late Phase and Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Sushma Bharadwaj, MD, MS1*, Mark P Hamilton, MD2, Bita Sahaf, PhD3*, John Tamaresis, PhD4*, Sunita Patil5*, Paul J Hanson, PhD6*, Theresa Latchford, RN3*, Sally Arai, MD7, Laura J. Johnston, MD8, Robert Lowsky, MD8, Robert S. Negrin, MD8, Andrew R. Rezvani, MD9, Judith A Shizuru, MD, PhD1, Everett H Meyer, MD, PhD8*, Parveen Shiraz, MD8, Surbhi Sidana, MD10, Melody Smith, MD, MS11, Wen-Kai Weng, MD, PhD12, Lori Muffly, MD1, Crystal L. Mackall, MD13, Matthew J Frank, MD, PhD14, David B. Miklos, MD, PhD8 and Saurabh Dahiya, MD15

1Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
2Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
3Stanford University, Stanford
4Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA
5Stanford University, Stanford, CA
6Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
7Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA
8Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
9Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
10Division of BMT and Cell Therapy, Stanford University Hospital, Stanford, CA
11Adult Bone Marrow Transplant Service and Cellular Therapeutics Center, Stanford University, Stanford, CA
12Stanford Univ. School of Med., Stanford, CA
13Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
14Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
15University – School of Medicine - Hematology/Oncology, Stanford University, Palo Alto, CA

Kris Michael Mahadeo, MD1, Robert A. Baiocchi, MD, PhD2, Amer Beitinjaneh, MD, MPH, MSc3*, Sridhar Chaganti, MD4*, Sylvain Choquet, MD5*, Daan Dierickx, MD6*, Rajani Dinavahi, MD7, Laurence Gamelin, MD, PhD7*, Armin Ghobadi, MD8, Norma Guzman-Becerra, MS9*, Manher Joshi, MD9*, Aditi Mehta, DO7*, Sarah Nikiforow, MD, PhD10*, Ran Reshef, MD11*, Wei Ye, PhD9* and Susan Prockop, MD12

1MD Anderson Cancer Center, Houston, TX
2James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
3University of Miami/Jackson Memorial Hospital, Miami, FL
4Centre for Clinical Haematology, University Hospital Birmingham, Birmingham, United Kingdom
5Hospitalier Pitié Salpétrière, Paris, France
6University Hospitals Leuven, Leuven, Belgium
7Atara Biotherapeutics Inc., Thousand Oaks, CA
8Washington University, Division of Oncology, St. Louis, MO
9Atara Biotherapeutics, South San Francisco, CA
10Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
11Columbia University Medical Center, New York, NY
12Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA

Surbhi Sidana, MD1, Lauren C. Peres, PhD, MPH2*, Hamza Hashmi, MD3, Hitomi Hosoya, MD, PhD4, Christopher J. Ferreri, MD5, Shebli Atrash, MD6, Jack Khouri, MD7, Peter M. Voorhees, MD6, Danai Dima, MD8, Gary Simmons, DO9, Nilesh Kalariya5*, Vanna Hovanky10*, Sushma Bharadwaj, MD, MS11*, Sally Arai, MD12, David B. Miklos, MD, PhD11, Charlotte B Wagner, PharmD13*, James Davis, PharmD3*, Douglas W. Sborov, MD14, Taiga Nishihori, MD15, Melissa Alsina, MD**16, Frederick L. Locke, MD17, Rebecca Gonzalez, PharmD, BCOP17*, M. Hakan Kocoglu, MD18, Aishwarya Sannareddy, MBBS19*, Aimaz Afrough, MD20, Joseph P. McGuirk, DO21, Leyla O. Shune, MD21, Krina Patel, MD, MSc22 and Doris K. Hansen, MD15

1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
2H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
4Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Levine Cancer Institute, Charlotte, NC
7Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
8Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
9Virginia Commonwealth University Massey Cancer Center, Richmond, VA
10Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
11Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
12Division of BMT and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
13University of Utah Huntsman Cancer Institute, Salt Lake City, UT
14Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT
15Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
16Moffitt Cancer Center, Tampa, FL
17Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
18University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
19Division of Hematologic Malignancies, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX
20Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
21The University of Kansas Medical Center, Kansas City, KS
22Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Sattva S. Neelapu, MD1, Julio Chavez2, Alison R. Sehgal, MD3, Narendranath Epperla, MD, MS4,5, Matthew Ulrickson, MD6, Emanuel Bachy, MD, PhD7*, Pashna N. Munshi, MD8*, Carla Casulo, MD9, David G. Maloney, MD, PhD10, Sven de Vos, MD, PhD11, Ran Reshef, MD, MSc12, Lori A. Leslie, MD13*, Olalekan O. Oluwole, MBBS14, Ibrahim Yakoub-Agha, MD, PhD15, Rashmi Khanal, MD16*, Joseph D. Rosenblatt, MD17, Jiali Yan, MS18*, Qinghua Song, PhD18*, Weixin Peng, MS18*, Christine Lui, MS18*, Jacob Wulff, DrPH19*, Rhine R. Shen, PhD18*, Soumya Poddar, PhD18*, Harry Miao, MD, PhD18*, Sara Beygi, MD18* and Caron A. Jacobson, MD20

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of South Florida H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3UPMC Hillman Cancer Center, Pittsburgh, PA
4The Ohio State University Comprehensive Cancer Center, Columbus, OH
5The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
6Banner MD Anderson Cancer Center, Gilbert, AZ
7Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
8Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
9University of Rochester Medical Center - James P. Wilmot Cancer Center, Rochester, NY
10Fred Hutchinson Cancer Research Center, Seattle, WA
11Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA
12Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY
13John Theurer Cancer Center, Hackensack, NJ
14Vanderbilt University Medical Center, Nashville, TN
15CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000 Lille, France
16Fox Chase Cancer Center, Philadelphia, PA
17University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
18Kite, a Gilead Company, Santa Monica, CA
19Kite, A Gilead Company, Santa Monica
20Dana-Farber Cancer Institute, Boston, MA

Fan Yang, MD1*, Rui Liu1*, Teng Xu2*, Peihao Zheng, MD1*, Shaomei Feng, MD1*, Yuelu Guo, MD1*, Lixia Ma, MD1*, Hui SHI1*, Biping Deng3*, Xiaoyan Ke, MD, PHD1*, Tong Wu, MD4 and Kai Hu, M.D., Ph.D.1*

1Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China
2Department of Data Statistics, Beijing GoBroad Boren Hospital, Beijing, China
3Cytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China
4Department of Hematology, Beijing GoBroad Boren Hospital, Beijing, China

John C. Molina, MD, MEd1, Vasant Chinnabhandar, MD, MBBS2*, Vanessa A Fabrizio, MD3, Michael Kunicki4*, Holly Pacenta, MD5, Jenna Rossoff, MD6, Heather E Stefanski, MD7, Julie-An Talano, MD 8, Amy Moskop, MD, MS9, Michael R Verneris, MD10, Gary Douglas Myers, MD11*, Nicole Karras, MD12*, Christina Baggott, RN, PhD13*, Muna Qayed, MD, MSc14, Michelle L. Hermiston, MD, PhD15, Prakash Satwani, MD16*, Christa Krupski, DO, MPH17*, Amy K. Keating, MD18*, Susanne H.C. Baumeister, MD19, Kevin J. Curran, MD20, Crystal L. Mackall, MD21, Theodore W. Laetsch, MD22*, Liora M. Schultz, MD23 and Stephanie M. Smith, MD24

1Leukemia and Myeloid Disorders Division, Cleveland Clinic, Cleveland, OH
2Perth Children's Hospital, Nedlands, AUS
3Department of Pediatrics, Weill Cornell Medical College, New York, NY
4Stanford University School of Medicine, Department of Pediatrics, Division of Hematology and Oncology, Palo Alto, CA
5Cook Children's Medical Center, Fort Worth, TX
6Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
7CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program®/Be The Match®, Mendota Heights, MN
8Department of Pediatrics, Hematology/Oncology and BMT, Medical College of WI, Milwaukee, WI
9CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
10Children's Hospital Colorado, University of Colorado At Denver, Aurora, CO
11Children's Mercy of Kansas City, Kansas City, MS
12City of Hope, Duarte, CA
13Stanford University School of Medicine, Stanford, CA
14Emory University, Atlanta, GA
15Pediatric Hematology Oncology, University of California San Francisco, San Francisco, CA
16Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
17Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
18Pediatric Blood and Marrow Transplantation, University of Colorado, Anschutz Medical Campus, Colorado Children’s Hospital, Aurora, CO
19Division of Pediatric Oncology, Dana Farber Cancer Inst./Children's Hospital Boston, Boston, MA
20Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
21Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
22Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
23Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
24Department of Pediatrics, Stanford University School of Medicine, Stanford, CA

Eolia Brissot1*, Christophe Peczynski2*, Myriam Labopin, MD3,4*, Federico Lussana, MD, PhD5*, Rachael Hough, MD6*, Jurgen Kuball, MD7, Wolf Roesler, M.D.8*, Sabine Furst, MD9*, Pere Barba, MD, PhD10,11*, Michael Daskalakis, MD12*, Tayfun Gungor13*, Marc Bierings, MD, PhD14, Caroline Besley, FRCPath, PhD15*, Ioanna Sakellari16*, Dimitrios Karakasis, MD17, Mi Kwon, MD, PhD18*, Nathalie Fegueux, MD19*, Annalisa Ruggeri, MD, PhD20*, Christian Chabannon, MD-PhD21, Sebastian Giebel, MD, PhD22*, Zinaida Peric, MD, PhD23*, Arnon Nagler, MD24, Fabio Ciceri, MD25* and Mohamad Mohty, MD PhD26

1Service d'Hématologie Clinique et de Thérapie Cellulaire, Hospital Saint Antoine, Paris Cedex 12, France
2EBMT Paris study office; Department of Haematology,, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
3Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France
4Acute Leukemia Working Party of EBMT, Paris, France
5Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Please Choose A State, Italy
6University College London Hospital, London, United Kingdom
7Department of Hematology, UMC Utrecht, Utrecht, Netherlands
8University Hospital Erlangen, Erlangen, Germany
9Hematology Department, Institut Paoli-Calmettes, Marseille, France
10Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
11Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
12Department of Hematology, 9- University Hospital Bern, Paediatric Hematology/Oncology Insel Gruppe AG, Kreditorenbuchhaltung, Freiburgst, Bern, Switzerland
13Division of Stem Cell Transplantation, The Hospital of the Eleonore Fondation,University Children`s Hospital, ZüRich, Switzerland
14Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
15University Hospitals Bristol, Bristol, United Kingdom
16Hematology Department and HCT Unit, George Papanikolaou General Hospital, THESSALONIKI, AL, Greece
17Evangelismos General Hospital, Department of Haematology and Bone Marrow Transplantation Unit, Athens, Greece
18Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
19Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
20IRCCS San Raffaele Scientific Institute, Hematology and Bone Marrow Transplant Unit, Milan, Italy
21Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France
22Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice, Poland
23University Hospital Centre Zagreb, Zagreb, Croatia
24Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
25Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
26EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France

Sanjal H Desai, MBBS1,2, Marcus P. Watkins, PhD3*, Reem Karmali, MD, MSc4, Gaurav Goyal, MD5, Mitchell Hughes, PharmD6*, Arushi Khurana, M.B.B.S.2*, Francisco Hernandez-Ilizaliturri, MD7, Nuttavut Sumransub, MD8, Joanna Zurko, MD9*, Imran A. Nizamuddin, MD10, Haris Hatic, DO11, Daniel A Landsburg, MD12*, Andrea Anampa-Guzman, MD13*, Mehdi Hamadani, MD14, Yi Lin, MD, PhD15, Iris Isufi, MD16, Aung M Tun, MD17, Brian T. Hill, MD, PhD18, Deborah M. Stephens, DO19, Paolo F Caimi, MD18, Daniel A. Ermann, MD20, Brad S. Kahl, MD21 and Grzegorz S. Nowakowski, MD2

1University of Minnesota, Division of Hematology Oncology Transplantation, Minneapolis, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Oncology, Washington University School of Medicine, St. Louis, MO
4Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
5Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
6Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
7Roswell Park Cancer Institute, Buffalo, NY
8Masonic Cancer Center, University of Minnesota, Minneapolis, MN
9Medical College of Wisconsin, Milwaukee, WI
10Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
11University of Alabama Medicine, Birmingham, AL
12University of Pennsylvania, Philadelphia, PA
13Roswell Park Comprehensive Cancer Center, Buffalo, NY
14The BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
15Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
16Hematology, Yale University School of Medicine, New Haven, CT
17Department of Medicine, Division of Hematology and Oncology, The Brooklyn Hospital Center, Westwood, KS
18Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
19Huntsman Cancer Institute, Salt Lake City, UT
20Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE
21Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO

Francis A. Ayuk, MD1*, Nico Gagelmann2*, Gerald Wulf, MD3*, Bastian von Tresckow, MD4, Kai Rejeski, MD5, Matthias Stelljes, MD6, Olaf Penack, MD7*, Claudia D. Baldus, MD8*, Nicolaus Kröger, MD2,9*, Wolfgang Bethge, MD10* and Peter Dreger, MD11,12*

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
3Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
4Department I of Internal Medicine, West German Cancer Center Essen, Essen, Germany
5Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
6Department of Hematology, Oncology and Pneumology, University of Münster, Münster, Germany
7Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany
8Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany
9German Stem Cell Transplant Registry (DRST), Ulm, Germany
10Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany
11German Lymphoma Alliance, Munich, Germany
12Department of Medicine V, University of Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany

Madiha Iqbal, MD1, Arushi Khurana, MBBS2, Julio Chavez3, Allison C. Rosenthal, DO4, Zhuo Li, MS5*, Emily Craver5*, Saha Aditi3*, Narendranath Epperla, MD, MS6, Kaitlin Annunzio, DO6, Farrukh T. Awan, MD7, Iris Isufi, MD8, Bhagirathbhai Dholaria, MBBS9, Shakthi Bhaskar9*, Joseph Maakaron, MD10*, Nuttavut Sumransub, MD10, Andrew Fijalka11*, Jose Sandoval-Sus12*, Stanislav Ivanov12*, Yi Lin, MD, PhD2 and Mohamed A. Kharfan-Dabaja, MD, MBA13

1Mayo Clinic, Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Jacksonville, FL
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
5Mayo Clinic, Division of Biomedical Statistics and Informatics, Jacksonville, FL
6The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
7Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
8Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
9Vanderbilt University Medical Center and Vanderbilt- Ingram Cancer Center, Nashville, TN
10Masonic Cancer Center, University of Minnesota, Minneapolis, MN
11M Health Fairview University of Minnesota Medical Center, Minneapolis, MN
12Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
13Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL

Olalekan O. Oluwole, MBBS1, Edouard Forcade, MD, PhD2, Javier Muñoz, MD, MS, MBA, FACP3, Sophie de Guibert, MD4*, Julie M. Vose, MD, MBA5, Nancy L. Bartlett, MD6, Yi Lin, MD, PhD7, Abhinav Deol, MD8, Peter A. McSweeney, MD9*, Andre H. Goy, MD10*, Marie José Kersten, MD, PhD11, Caron A. Jacobson, MD12, Umar Farooq, MD13, Monique C. Minnema, MD, PhD14, Catherine Thieblemont, MD, PhD15, John Timmerman, MD16, Patrick Stiff, MD17, Irit Avivi, MD18*, Dimitrios Tzachanis, MD, PhD19, Yan Zheng, MS20*, Saran Vardhanabhuti, PhD20*, Jenny Nater, MS20*, Rhine R. Shen, PhD20*, Harry Miao, MD, PhD20*, Jenny Kim, MD20* and Tom van Meerten, MD, PhD21,22*

1Vanderbilt University Medical Center, Nashville, TN
2Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
3Banner MD Anderson Cancer Center, Gilbert, AZ
4Hématologie Clinique, CHU Rennes, Rennes, France
5University of Nebraska Medical Center, Omaha, NE
6Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
7Division of Hematology, Mayo Clinic, Rochester, MN
8Karmanos Cancer Center, Wayne State University, Detroit, MI
9Colorado Blood Cancer Institute, Denver, CO
10John Theurer Cancer Center, Hackensack, NJ
11Amsterdam UMC, University of Amsterdam, on behalf of HOVON/LLPC, Amsterdam, Netherlands
12Dana-Farber Cancer Institute, Boston, MA
13University of Iowa, Iowa City, IA
14University Medical Center Utrecht, on behalf of HOVON/LLPC, Utrecht, Netherlands
15Paris University; Assistante publique-Hôpitaux de Paris, Hemato-oncology, Paris, France
16UCLA David Geffen School of Medicine, Los Angeles, CA
17Loyola University Chicago Stritch School of Medicine, Maywood, IL
18Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
19University of California San Diego, La Jolla, CA
20Kite, a Gilead Company, Santa Monica, CA
2121University Medical Center Groningen, on behalf of HOVON/LLPC, Groningen, Netherlands
22Department of Hematology, University Medical Center Groningen, Groningen, DC, Netherlands

Ricardo Villanueva1*, Doris K. Hansen, MD2, Rolf Petter Tonseth, MD3*, Kenneth L Gage, MD PhD4*, Zhouping Wei5*, Gabriel De Avila, BS6*, Rachid C. Baz, MD7, Ariel F Grajales-Cruz, MD8, Omar Castaneda-Puglianini, MD2*, Brandon J. Blue, MD9, Jason Brayer, MD, PhD8, Kenneth H. Shain, MD, PhD8, Melissa Alsina, MD**10, Hien D. Liu, MD2, Taiga Nishihori, MD2, Meghan A Menges11*, Frederick L. Locke, MD11, Yoganand Balagurunathan, PhD10* and Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP6

1University of South Florida, Tampa, FL
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
3Department of Functional Imaging, British Columbia Cancer Center, Victoria, BC, Canada
4Department of Functional Imaging, Moffitt Lee Cancer Center, Tampa
5Moffitt Lee Cancer Center, Tampa, FL
6Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
7Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
9Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
10Moffitt Cancer Center, Tampa, FL
11Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Kai Rejeski, MD1,2,3, David M. Cordas dos Santos, MD1,4,5*, Paul Trinkner1,5*, Sophie Guenther1,5*, Lian Liu, MD6*, Michael Winkelmann, MD7*, Veit L Buecklein, MD1,8*, Viktoria Blumenberg, MD1,3,8, Christian Schmidt, MD1*, Philipp Karschnia, MD9*, Wolfgang G. Kunz, MD7*, Michael von Bergwelt, Prof. Dr.1,3,6*, Sebastian Theurich, MD1,3,5* and Marion Subklewe, MD2,3,10

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Laboratory for Translational Cancer Immunology, Gene Center, LMU, Munich, Germany
3German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany
4German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center (DKFZ), Heidelberg, Germany
5Cancer and Immunometabolism Research Group, Gene Center, LMU Munich, Munich, Germany
6Comprehensive Cancer Center (CCC), LMU Munich, Munich, Germany
7Department of Radiology, University Hospital, LMU Munich, Munich, Germany
8Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
9Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany
10Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Munich, Germany

Peter Bader, MD, PhD1, Claudia Rossig, MD, PhD2, Martin Hutter3*, Francis A. Ayuk, MD4*, Claudia D. Baldus, MD5*, Veit L Buecklein6*, Halvard Bonig, MD, PhD7, Gunnar Cario, MD, PhD8*, Hermann Einsele, MD9, Udo Holtick, MD, PhD10*, Christian Koenecke, MD11*, Annette Künkele, MD12*, Roland Meisel, MD13, Fabian Mueller, MD14*, Ingo Müller, MD15*, Olaf Penack, MD16*, Eva Rettinger, MD, PhD3*, Martin G. Sauer, MD17, Paul-Gerhardt Schlegel18, Jan Soerensen, MD3*, Arend von Stackelberg, MD12, Tobias Feuchtinger, MD19 and Andrea Jarisch, MD3*

1Division for Stem Cell Transplantation, Immunology and Intensive Care, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany
2Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
3Department for Children and Adolescents, University Hospital, Goethe University, Division for Stem Cell Transplantation, Immunology and Intensive Care, Frankfurt, Germany
4Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany
6Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
7Goethe University Institute for Transfusion Medicine and Immunohematology, Translational Development of Cellular Therapies, and German Red Cross Blood Service Baden-Württemberg-Hesse, Frankfurt, Germany
8Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany, Kiel, Schleswig-Holstein, Germany
9Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany
10Department I of Internal Medicine, Department I of Internal Medicine,, University Hospital Cologne, Department I of Internal Medicine,, Cologne, Germany
11Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
12Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universiät zu Berlin, Department of Pediatric Oncology and Hematology, Berlin, Germany
13Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
14Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany
15University Medical Center Hamburg-Eppendorf, Division of Pediatric Stem Cell transplantation and Immun, Hamburg, Germany
16Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany
17Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
18University Children's Hospital Wuerzburg, Wuerzburg, Germany
19Department Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany

Abu-Sayeef Mirza, MD, MPH1, Alexander Pine, MD, PhD2, Yusuf Rasheed3*, Ramzi Hamouche, MD3*, Etienne Leveille, MD4, George Goshua, MD, MSc5, Sean Gu, MD, PhD1*, Yuxin Liu, MD6, Jennifer VanOudenhove, PhD7*, Noffar Bar, MD8, Natalia Neparidze, MD7, Francine M. Foss, MD9, Lohith Gowda, MD10, Iris Isufi, MD10, Stephanie Halene, MD11, Alfred I Lee, MD, PhD12 and Stuart Seropian, MD10

1Yale School of Medicine, New Haven, CT
2Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT
3Yale University, New Haven, CT
4Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT
5Section of Hematology, Yale University School of Medicine, New Haven, CT
6Yale University School of Medicine, Fairfield, CT
7Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
8Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, CT
9Yale University School of Medicine, New Haven, CT
10Hematology, Yale University School of Medicine, New Haven, CT
11Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
12Classical Hematology, Section of Hematology, Yale University School of Medicine, New Haven, CT

Olaf Penack, MD1*, Christophe Peczynski2*, Christian Koenecke, MD3*, Emmanuelle Polge, M.Sc4*, Victoria Potter5*, Ibrahim Yakoub-Agha, MD, PhD6, Nathalie Fegueux, MD7*, Michael Daskalakis, M.D.8*, Matthew P. Collin, MD, PhD9, Peter Dreger, MD10, Nicolaus Kröger, MD11*, Urs Schanz, MD12, Adrian Bloor, PhD FRCP FRCPath13*, Arnold Ganser, MD14*, Caroline Besley, FRCPath, PhD15*, Gerald Wulf, MD16*, Urban Novak17*, Ivan Moiseev, MD18, Helene Schoemans, MD19*, Grzegorz W Basak, MD, PhD20*, Christian Chabannon, MD-PhD21, Anna Sureda22, Bertram Glass23* and Zinaida Peric, MD, PhD24*

1Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany
2EBMT Paris study office; Department of Haematology,, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
3Institute of Immunology, Hannover Medical School, Hannover, Germany
4ALWP of the EBMT Paris office, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
5BSBMTCT, King's College Hospital NHS Foundation Trust, London, United Kingdom
6Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, LILLE, France
7Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
8Department of Hematology and Central Hematology Laboratory, University Hospital, Bern, Switzerland
9Adult HSCT unit, Newcastle, United Kingdom, Newcastle, United Kingdom
10Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
11University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
12Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
13Haematology, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
14Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
15Bristol Royal Hospital for Children, Dept. of Paediatric Oncology/BMT, Bristol, United Kingdom
16Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
17The Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
18RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russia
19Department of Hematology, University Hospitals Leuven and KU Leuven, Leuven, Belgium
20Department of Hematology, Transplantation, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
21Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France
22Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain
23Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany
24University Hospital Centre Zagreb, Zagreb, Croatia

Yuliya Linhares, MD1*, Cesar Freytes, MD2, Mohamad Cherry, MD, MS3, Carlos Bachier, MD2, Michael Maris, MD4*, Daanish Hoda, MD5, Juan Carlos Varela, MD, PhD6, Courtney Bellomo, MD7*, Scott Cross, MD8*, James Essell, MD9, Suzanne Fanning, DO10, Howard Terebelo, DO11*, Habte A. Yimer12, Jay Courtright, MD13*, Jeff P. Sharman, MD14, Min Vedal, PhD15*, Connor Mailley16*, Ricardo Espinola, MD17* and Bassam Mattar, MD, FACP18*

1Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health, Miami, FL
2Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital, San Antonio, TX
3Atlantic Health System, Carol Simon Cancer Center, Morristown, NJ
4Colorado Blood and Cancer Institute and Sarah Cannon Research Institute, Denver, CO
5Intermountain Healthcare, Loveland Clinic for Blood Cancer Therapy, Salt Lake City, UT
6Advent Health, Orlando, FL
7Albany Medical Center, Albany, NY
8Virginia Oncology Associates, Norfolk, VA
9Oncology Hematology Care, Cincinnati, OH
10Prisma Health, Greenville, SC
11Ascension St. John Newland Medical Associates, Southfield, MI
12Texas Oncology-Tyler, Tyler, TX
13Texas Oncology, Medical City Dallas, Dallas, TX
14Willamette Valley Cancer Institute, Eugene, OR
15Bristol Myers Squibb, Seattle, WA
16Bristol Myers Squibb, Princeton, NJ
17Bristol Myers Squibb, San Diego, CA
18Cancer Center of Kansas, Wichita, KS

Anthony J Ross, MD1, Christina Baggott, RN, PhD2*, Snehit Prabhu, PhD2*, Holly Pacenta, MD3, Christine Philips4*, Jenna Rossoff, MD5, Heather E Stefanski, MD6, Julie-An Talano, MD 7, Amy Moskop, MD, MS8, Susanne H.C. Baumeister, MD9, Michael R Verneris, MD10, Gary Douglas Myers, MD11*, Nicole Karras, MD12*, Muna Qayed, MD, MSc13, Michelle L. Hermiston, MD, PhD14, Prakash Satwani, MD15*, Christa Krupski, DO, MPH16*, Amy K. Keating, MD17*, Rachel Wilcox18*, Vanessa A Fabrizio, MD19, Vasant Chinnabhandar, MD20*, Kevin J. Curran, MD21, Crystal L. Mackall, MD22, Theodore W. Laetsch, MD23*, Sandra K Althouse, PhD24*, Shannon L. Maude, MD25, Curtis J Henry, PhD26, Liora M. Schultz, MD27 and Jodi L. Skiles, MD28*

1Indiana University School of Medicine/Riley Hospital for Children, Indianapolis, IN
2Stanford University School of Medicine, Stanford, CA
3Cook Children's Medical Center, Fort Worth, TX
4Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
6CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program®/Be The Match®, Mendota Heights, MN
7Department of Pediatrics, Hematology/Oncology and BMT, Medical College of WI, Milwaukee, WI
8CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
9Division of Pediatric Oncology, Dana Farber Cancer Inst./Children's Hospital Boston, Boston, MA
10Children's Hospital Colorado, University of Colorado At Denver, Aurora, CO
11Children's Mercy of Kansas City, Kansas City, MS
12Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
13Emory University, Atlanta, GA
14Pediatric Hematology Oncology, University of California San Francisco, San Francisco, CA
15Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
16Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
17Pediatric Blood and Marrow Transplantation, University of Colorado, Anschutz Medical Campus, Colorado Children’s Hospital, Aurora, CO
18Childern's Mercy Hospital, Kansas
19University of Colorado, Anschutz Medical Campus, Colorado Children's Hospital, Aurora, CO
20Department of Pediatrics, Division of Pediatric Blood and Marrow Transplantation, University of Minnesota Medical School, Minneapolis, MN
21Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
22Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
23Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
24Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN
25Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA
26Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
27Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
28Riley Hospital for Children, Indianapolis, IN

Hui Shi, MD1*, Kai Hu, M.D., Ph.D.1*, Fan Yang, MD1*, Zhuojun Liu, PhD2*, Jia Liu, PhD2*, Wei Chen, PhD2* and Jian Yu, PhD2*

1Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China
2School of Engineering Medicine, Beihang University, Beijing, China

Andrew Jallouk, MD, PhD1, Lei Feng, MS2*, Mansoor Noorani3*, Kaberi Das4*, Raphael E Steiner, MD5, Loretta J. Nastoupil, MD5, Misha Hawkins6*, Ranjit Nair, MD7, Jason Westin, MD8, Luis Fayad, MD9, Dai Chihara, MD9, Luis Enrique Malpica Castillo, MD8, Swaminathan P. Iyer, MD9, Sairah Ahmed, MD10, Elizabeth J Shpall, MD11, Partow Kebriaei, MD12, Sattva S. Neelapu, MD13 and Paolo Strati, MD9

1MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3UTMDACC, Houston
4UT MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
7Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
8The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
11Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
12Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
13Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Jack Khouri, MD1, Hong Li, MS2*, Doris K. Hansen, MD3, Surbhi Sidana, MD4, Leyla O. Shune, MD5, Shaun DeJarnette6*, Faiz Anwer, MD1*, Douglas W Sborov7*, Charlotte B Wagner, PharmD7*, M. Hakan Kocoglu, MD8, Shebli Atrash, MD9, Peter M. Voorhees, MD10, Jason Valent, MD1, Lauren C. Peres, PhD, MPH11*, Vanna Hovanky12*, Gary Simmons, DO13, Danai Dima, MD1, Nilesh Kalariya14*, Aimaz Afrough, MD15, Gurbakhash Kaur, MD16*, Aishwarya Sannareddy, MBBS17*, Christopher J. Ferreri, MD14, James Davis, PharmD18*, Joseph P. McGuirk, DO19, Frederick L. Locke, MD20, Rachid C. Baz, MD21, Betty K. Hamilton, MD22, Melissa Alsina, MD**23, Craig S. Sauter, MD24*, Hamza Hashmi, MD18 and Krina Patel, MD, MSc25

1Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
2Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
4Stanford University School of Medicine, Stanford, CA
5Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), University of Kansas Medical Center, Kansas City, KS
6Kansas University Medical Centre, Kansas City
7University of Utah Huntsman Cancer Institute, Salt Lake City, UT
8University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
9Levine Cancer Institute, Charlotte, NC
10Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
11H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
12Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
13Virginia Commonwealth University Massey Cancer Center, Richmond, VA
14The University of Texas MD Anderson Cancer Center, Houston, TX
15Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
16Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
17Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX
18Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
19Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
20Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
21Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL
22Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
23Moffitt Cancer Center, Tampa, FL
24Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH
25Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Nilanjan Ghosh, PhD, MD1*, Alison R. Sehgal, MD2, Fei Fei Liu, BSc, MBA3*, Ana Kostic, MD4*, Alessandro Crotta, MD5*, Lily Peng, MS6*, Marc De Benedetti, PhD7* and Leo I. Gordon, MD8

1Levine Cancer Institute, Atrium Health, Charlotte
2University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
3Bristol Myers Squibb, Princeton, NJ
4Bristol Myers Squibb, Seattle, WA
5Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
6Bristol Myers Squibb, Seattle
7Bristol Myers Squibb, Princeton
8Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago

*signifies non-member of ASH